stockportfolio.pro
Bristol-Myers Squibb Company Gross Profit 2007–2025
Bristol-Myers Squibb Company (BMY) annual gross profit by fiscal year, computed from SEC filings. Compound growth +6.7%/yr over 18 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $34.26B | 71.1% | -0.2% |
| FY 2024 | $34.33B | 71.1% | +0.1% |
| FY 2023 | $34.31B | 76.2% | -4.7% |
| FY 2022 | $36.02B | 78.0% | -1.2% |
| FY 2021 | $36.45B | 78.6% | +18.5% |
| FY 2020 | $30.75B | 72.3% | +70.2% |
| FY 2019 | $18.07B | 69.1% | +12.3% |
| FY 2018 | $16.09B | 71.3% | +9.6% |
| FY 2017 | $14.68B | 70.7% | +1.4% |
| FY 2016 | $14.48B | 74.5% | +14.5% |
| FY 2015 | $12.65B | 76.4% | +5.9% |
| FY 2014 | $11.95B | 75.2% | +1.5% |
| FY 2013 | $11.77B | 71.8% | -9.6% |
| FY 2012 | $13.01B | 73.8% | -16.8% |
| FY 2011 | $15.65B | 73.6% | +10.1% |
| FY 2010 | $14.21B | 72.9% | +3.9% |
| FY 2009 | $13.67B | 72.7% | +10.2% |
| FY 2008 | $12.40B | 70.0% | +15.9% |
| FY 2007 | $10.70B | 68.5% | — |
Source: Bristol-Myers Squibb Company SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Bristol-Myers Squibb Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBristol-Myers Squibb Company — frequently asked questions
What is Bristol-Myers Squibb Company's gross profit?
Bristol-Myers Squibb Company (BMY) reported gross profit of $34.26B for fiscal year 2025, per its SEC filings.
How has Bristol-Myers Squibb Company's gross profit changed over time?
Between fiscal 2007 and 2025, BMY's gross profit grew at roughly 6.7% per year (compound annual rate), from $10.70B to $34.26B.
Where does this data come from?
Figures are computed from Bristol-Myers Squibb Company's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.